Letter to the editorInhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid
References (10)
- et al.
Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients
Gen Pharmacol
(1985) - et al.
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
EMBO J
(2001) - et al.
The effects of the histone deacetylase inhibitor valproic acid on cell cycle, growth suppression and apoptosis in multiple myeloma
Haematologica
(2006) - et al.
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity
Clin Cancer Res
(2007) - et al.
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Genes Dev
(2010)
There are more references available in the full text version of this article.
Cited by (0)
Supported by the Federal Ministry of Education and Research (BMBF 01 EO 0803 to M.R.) and by the Deutsche Krebshilfe (project no. 108935 to H.E.).
Disclosure of potential conflict of interest: S. L. Nutt has been supported by one or more grants from the National Health and Medical Research Council of Australia. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.